基于CT的影像组学预测膀胱癌肌层浸润
该回顾性研究纳入两个医学中心2014年10月至2020年5月接受CT尿路造影且术后病理证实为膀胱尿路上皮癌的441例患者,提取1218个特征并用逻辑回归构建预测模型,模型在训练组、内部测试组和外部测试组诊断肌层浸润性膀胱癌的AUC分别为0.885、0.820和0.784。
要点
- 基于CT的影像组学模型可在术前评估膀胱癌肌层浸润状态,外部测试组AUC为0.784。
- 内部测试组敏感度0.667、特异度0.845、准确率0.782;外部测试组敏感度0.742、特异度0.750、准确率0.782。
- 作者认为该术前CT预测方法可能补充MR对膀胱癌的评估并辅助活检。
核心结论
- 基于CT的影像组学预测模型可在术前评估膀胱癌肌层浸润性,诊断性能良好。
研究设计与样本
- 回顾性纳入两个医学中心2014年10月至2020年5月接受CT尿路造影且术后组织病理学证实为膀胱尿路上皮癌的患者441例。
- 病例随机分为训练组293例、内部测试组73例和外部测试组75例。
- 图像经滤波后提取1218个特征,采用方差分析筛选与膀胱癌肌层浸润相关的最佳特征。
- 采用逻辑回归方法构建预测模型,通过绘制受试者工作特征曲线进行统计分析。
诊断标准与关键数值
- 训练组诊断肌层浸润性膀胱癌的AUC为0.885(95%CI 0.841-0.929)。
- 内部测试组诊断肌层浸润性膀胱癌的AUC为0.820(95%CI 0.698-0.941),敏感度0.667(95%CI 0.387-0.870)、特异度0.845(95%CI 0.721-0.922)、准确率0.782(95%CI 0.729-0.827)。
- 外部测试组诊断肌层浸润性膀胱癌的AUC为0.784(95%CI 0.674-0.893),敏感度0.742(95%CI 0.551-0.873)、特异度0.750(95%CI 0.594-0.863)、准确率0.782(95%CI 0.729-0.827)。
临床应用与阅片要点
- 作者认为该术前基于CT的预测方法可能补充MR对膀胱癌的评估并辅助活检。
- 原文未据此给出面向日常阅片或报告流程的具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study investigated the feasibility of a computed tomography (CT)-based radiomics prediction model to evaluate muscle invasive status in bladder cancer.
METHODS: Patients who underwent CT urography at two medical centers from October 2014 to May 2020 and had bladder urothelial carcinoma confirmed by postoperative histopathology were retrospectively enrolled. In total, 441 cases were collected and randomized into a training cohort (n = 293), an internal testing cohort (n = 73), and an external testing cohort (n = 75). The images were first filtered, and then, 1218 features were extracted. The best features related to muscle invasiveness of bladder cancer were identified by ANOVA. A prediction model was built by using the logistic regression method. Statistical analysis was performed by plotting the receiver operating characteristic curve. Indicators of the diagnostic performance of the prediction model, including sensitivity, specificity, accuracy, and area under curve (AUC), were evaluated.
RESULTS: In the training, internal testing, and external testing cohorts, the prediction model diagnosed muscle-invasive bladder cancer with AUCs of 0.885 (95% confidence interval [95% CI] 0.841-0.929), 0.820 (95% CI 0.698-0.941), and 0.784 (95% CI 0.674-0.893), respectively. In the internal testing cohort, the sensitivity, specificity, and accuracy of the model were 0.667 (95% CI 0.387-0.870), 0.845 (95% CI 0.721-0.922), and 0.782 (95% CI 0.729-0.827), respectively. In the external testing cohort, the sensitivity, specificity, and accuracy of the model were 0.742 (95% CI 0.551-0.873), 0.750 (95% CI 0.594-0.863), and 0.782 (95% CI 0.729-0.827), respectively.
CONCLUSIONS: CT-based radiomics prediction model can evaluate muscle invasiveness of bladder cancer before surgery with a good diagnostic performance.
KEY POINTS: • CT-based radiomics model can evaluate muscle invasive status in bladder cancer. • The radiomics model shows good diagnostic performance to differentiate muscle-invasive bladder cancer from non-muscle-invasive bladder cancer. • This preoperative CT-based prediction method might complement MR evaluation of bladder cancer and supplement biopsy.
引用
- Zhang, Wu, Zhang, et al. CT-based radiomics to predict muscle invasion in bladder cancer. Eur Radiol. 2022. PMID: 35064316. doi:10.1007/s00330-021-08426-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。